Showing 1 - 5 results of 5 for search 'Carlos G. Ramos-Becerra', query time: 0.03s Refine Results
  1. 1
    P23 Tadalafil improves hemodynamic parameters and arterial stiffness in patients with grade I-II obesity without comorbidities

    P23 Tadalafil improves hemodynamic parameters and arterial stiffness in patients with grade I-II obesity without comorbidities by Mariana Larios-Cardenas, Fernando Grover-Páez, David Cardona-Muller, Ernesto Cardona, Oscar I. Gonzalez-Radillo, Jonathan Trujillo-Quiros, Marycruz Barocio-Pantoja, Patricia Quezada-Fernandez, Carlos G. Ramos-Becerra

    Published 2020-02-01
    Get full text
    Article
  2. 2
    Aortic stiffness and central hemodynamics in treatment-naïve HIV infection: a cross-sectional study

    Aortic stiffness and central hemodynamics in treatment-naïve HIV infection: a cross-sectional study by Pedro Martínez-Ayala, Guillermo Adrián Alanis-Sánchez, Luz Alicia González-Hernández, Monserrat Álvarez-Zavala, Rodolfo Ismael Cabrera-Silva, Jaime Federico Andrade-Villanueva, Karina Sánchez-Reyes, Moisés Ramos-Solano, Diego Alberto Castañeda-Zaragoza, David Cardona-Müller, Sylvia Totsuka-Sutto, Ernesto Cardona-Muñoz, Carlos G. Ramos-Becerra

    Published 2020-10-01
    Get full text
    Article
  3. 3
    Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial

    Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial by Luis Ricardo Balleza Alejandri, Fernando Grover Páez, Erick González Campos, Carlos G. Ramos Becerra, Ernesto Germán Cardona Muñóz, Sara Pascoe González, María Guadalupe Ramos Zavala, Africa Samantha Reynoso Roa, Daniel Osmar Suárez Rico, Alberto Beltrán Ramírez, Jesús Jonathan García Galindo, David Cardona Müller, Claudia Yanette Galán Ruíz

    Published 2024-06-01
    Get full text
    Article
  4. 4
    Correction: Balleza Alejandri et al. Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial. <i>J. Cardiovasc. Dev. Dis.</i> 2024, <i>11</i>, 182

    Correction: Balleza Alejandri et al. Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial.... by Luis Ricardo Balleza Alejandri, Fernando Grover Páez, Erick González Campos, Carlos G. Ramos Becerra, Ernesto Germán Cardona Muñóz, Sara Pascoe González, María Guadalupe Ramos Zavala, Africa Samantha Reynoso Roa, Daniel Osmar Suárez Rico, Alberto Beltrán Ramírez, Jesús Jonathan García Galindo, David Cardona Müller, Claudia Yanette Galán Ruíz

    Published 2024-10-01
    Get full text
    Article
  5. 5
    YKL-40 serum levels are predicted by inflammatory state, age and diagnosis of idiopathic inflammatory myopathies

    YKL-40 serum levels are predicted by inflammatory state, age and diagnosis of idiopathic inflammatory myopathies by Mónica Vázquez-Del Mercado, Felipe Pérez-Vázquez, Ana L. Márquez-Aguirre, Erika-Aurora Martínez-García, Efrain Chavarria-Avila, Carlos G. Ramos-Becerra, Andrea Aguilar-Vázquez, Marisol Godínez-Rubí, Beatriz-Teresita Martín-Márquez, Livier Gómez-Limón, Guillermo Márquez-De-La-Paz, Edy-David Rubio-Arellano, Oscar Pizano-Martinez

    Published 2023-11-01
    Get full text
    Article

Search Tools: